Insider filing · ATRA
Brian N Cherry
Director
profile →
Atara Biotherapeutics, Inc.
ATRA · Healthcare · 6 filings in 24 months
ticker →
Brian N Cherry bought $1000K of Atara Biotherapeutics (ATRA)
Executed Sep 4, disclosed Sep 4, the same day.
Value, as filed
$1000K
104,166 sh × $9.60
Executed
Sep 4
the trade date, as filed
Disclosed
Sep 4
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
BCBrian N Cherry (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Atara Biotherapeutics, Inc. (ATRA). The largest single filing was $1000K of ATRA (104,166 sh × $9.60, as filed), executed Sep 4. The median gap between execution and disclosure was 0 days.
The name
ATRAHealthcare · Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the U…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→